START will leverage Trialing’s platform to distribute curated information on ongoing early-phase oncology trials.

GEN announces approval in the Netherlands to initiate patient enrollment in April 2026 for the Phase II Proof of ...

GentiBio, Inc., a clinical-stage biotechnology company pioneering engineered, antigen-specific regulatory T cell (EngTreg) therapies, today announced that the first participant has been dosed in ...

Stem cells are gaining attention for their potential to treat leukemia, certain solid tumor cancers, and inherited metabolic ...

In a phase 2b clinical trial, an investigational oral therapy called PrimeC was found to be safe and well tolerated in people ...

For patients facing a multiple myeloma diagnosis, the journey is often defined by a search for the next line of defense. For survivor Julie Cohen, that search led her to the front lines of medical ...

MVID has a lethal natural history requiring life-sustaining parenteral support (PS), which includes total parenteral ...

Pregnant and breastfeeding women have historically been excluded from medical research, resulting in substantial gaps in ...

LAKE ZURICH, IL, UNITED STATES, March 17, 2026 /EINPresswire.com/ -- The Sikh community in the United States, estimated ...

PhaseWell Research ("PhaseWell"), a multisite clinical research company, today announced the strategic acquisition of Chase ...

Kyowa Kirin announced it is discontinuing all ongoing clinical trials for rocatinlimab, an investigational anti-OX40 ...

Bay State lawmakers are asking one of the nation’s top public health officials to provide more information on the number of clinical health trials that have been derailed under the second Trump ...